Loading provider…
Loading provider…
Surgery Physician in New York, NY
NPI: 1245313972Primary Employer
Laser Surgery Care
lasersurgerycare.com
HQ Phone
Get MD Stephen's Phone Numberphone_androidMobile
Get MD Stephen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Montefiore Medical Center
Residency • Surgery
1982 - 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 93 | 109 |
| 2 | 46600Diagnostic examination of the anus using an endoscope | 59 | 63 |
| 3 | 46606Biopsy of anus using an endoscope | 56 | 59 |
| 4 | 46601Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope | 37 | 41 |
| 5 | 99203New patient outpatient visit, total time 30-44 minutes | 17 | 17 |
Tolerability of anal dysplasia screening.
Authors: Davis, Tony W, Goldstone, Stephen E, Chen, Guorong
Journal: J Low Genit Tract Dis
Predictors of anal dysplasia in men who have sex with men with benign cytology.
Authors: Lee, Eric Q, Goldstone, Stephen E
Journal: Dis Colon Rectum
High rates of anal dysplasia in HIV-infected men who have sex with men, women, and heterosexual men.
Authors: Michael Gaisa, Jonathan Hand
Journal: AIDS
Lead Sponsor: AIDS Malignancy Consortium
Collaborators: National Cancer Institute (NCI), The Emmes Company, LLC, University of Arkansas, AIDS and Cancer Specimen Resource
Intervention / Treatment: PROCEDURE: Therapeutic Conventional Surgery
Lead Sponsor: AIDS Malignancy Consortium
Collaborators: National Cancer Institute (NCI), The Emmes Company, LLC, Inovio Pharmaceuticals
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DEVICE: Electroporation, BIOLOGICAL: HPV DNA Plasmids Therapeutic Vaccine VGX-3100
Lead Sponsor: Inovio Pharmaceuticals
Intervention / Treatment: BIOLOGICAL: VGX-3100, DEVICE: CELLECTRA™ 5PSP